Sign In
Buy ALNY
$216.98
-2.22 (-1.01%)
At Close: Aug 10, 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study
American Century Focused Dynamic Growth Fund Q3 2025 Performance Contributors And Detractors
08:10am, Wednesday, 05'th Nov 2025
Google's parent company received a relatively benign antitrust ruling that would not force Alphabet to sell its Chrome browser or Android operating system. Alnylam's shares benefited from a positive p
Alnylam Pharmaceuticals: Q3 Earnings Review - A Sensational Year Reaches Its Peak
03:58pm, Friday, 31'st Oct 2025
Alnylam Pharmaceuticals, Inc. delivered strong Q3 results, driven by Amvuttra's success in ATTR-CM, with total revenues soaring to $1.25 billion. ALNY's market cap surged to $59B as Amvuttra outperfor
ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra Sales
12:20pm, Friday, 31'st Oct 2025
Alnylam's Q3 earnings and revenues surge past forecasts, powered by booming Amvuttra sales and a key milestone payment from Roche.
Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2025 Earnings Call Transcript
02:46pm, Thursday, 30'th Oct 2025
Alnylam Pharmaceuticals, Inc. ( ALNY ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Christine Lindenboom - Chief Corporate Communications Officer Yvonne Greenstreet - CEO &
Why Is Alnylam Pharmaceuticals Stock Trading Lower Thursday?
02:39pm, Thursday, 30'th Oct 2025
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) stock is trading lower after the company reported third-quarter earnings.
Compared to Estimates, Alnylam (ALNY) Q3 Earnings: A Look at Key Metrics
11:30am, Thursday, 30'th Oct 2025
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Str
Alnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates
10:18am, Thursday, 30'th Oct 2025
Alnylam Pharmaceuticals (ALNY) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to a loss of $0.5 per share a year ago.
Alnylam Stock Has Already Doubled In 2025. Why It Could Rocket Again On Earnings.
08:00am, Thursday, 30'th Oct 2025
Alnylam stock could surge again after the biotech company easily beat Wall Street's third-quarter forecasts on the back of Amvuttra.
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
08:00am, Thursday, 30'th Oct 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended Se
Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS
10:16am, Tuesday, 28'th Oct 2025
Evaluate the expected performance of Alnylam (ALNY) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metric
Alnylam Pharmaceuticals, Inc. $ALNY Stock Position Lessened by Yousif Capital Management LLC
03:49am, Friday, 24'th Oct 2025
Yousif Capital Management LLC reduced its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 6.3% during the second quarter, according to the company in its most recent Form 13F fil
Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:05am, Thursday, 23'rd Oct 2025
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Alnylam (ALNY) Might be Well Poised for a Surge
01:21pm, Monday, 20'th Oct 2025
Alnylam Pharmaceuticals (ALNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
S&P 500's New AI Play? Walmart In Buy Zone, Leads Five Stocks To Watch Amid Volatile Market
08:00am, Saturday, 18'th Oct 2025
S&P 500 giant Walmart and a profitable biotech are actionable, leading five stocks to watch amid a tricky market environment.
